Guinea-Bissau suspends the use of the Oxford-AstraZeneca vaccine until May amid safety concerns regarding the vaccine, including fears about blood clots.
Guinea-Bissau suspends the use of the Oxford-AstraZeneca vaccine until May amid safety concerns regarding the vaccine, which including fears about blood clot.
Guinea-Bissau suspends the use of the Oxford-AstraZeneca vaccine until May amid safety concerns regarding the vaccine, including fears about blood clots.